Literature DB >> 17336555

Embolisation of symptomatic pelvic veins in women presenting with non-saphenous varicose veins of pelvic origin - three-year follow-up.

D Creton1, L Hennequin, F Kohler, F A Allaert.   

Abstract

AIM: To evaluate the clinical results of embolisation of symptomatic, incompetent pelvic veins in women presenting with perineal veins. PATIENTS AND METHODS: Twenty-four women presenting with non-saphenous perineal varicose veins and who experienced pelvic vein syndrome were treated. Symptoms was scored on a visual analogue scale assessing dyspareunia, pelvic and lower limb pain. Lower limb varices were investigated by duplex ultrasonography. Pelvic veins were studied by pelvic vein angiography with simultaneous embolisation of incompetent veins. Ovarian and internal iliac veins were systematically embolised when incompetent. Follow-up assessment of symptoms and varices was carried out at 1, 2 and 3 years.
RESULTS: All patients presented with perineal veins, 2 with sciatic vein incompetence and 2 with a perforator of the thigh or buttock. Pelvic venous angiography was performed via right femoral access in 87% of the cases and confirmed the presence of incompetent ovarian and internal iliac veins. The mean number of coils used per vein was 6 and all were successfully embolised. No serious complications were encountered. The mean clinical improvement score was 80%, 77%, 80% and 76% at respectively 45 days, 1, 2 and 3-year follow-up.
CONCLUSION: In women of reproductive age, non-saphenous varicose veins associated with pelvic venous incompetence (PVI) should undergo pelvic vein investigation. In this clinical series we achieved a satisfactory improvement in symptoms after 3 years following treatment of incompetent pelvic veins.

Entities:  

Mesh:

Year:  2007        PMID: 17336555     DOI: 10.1016/j.ejvs.2007.01.005

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  8 in total

Review 1.  Pelvic Congestion Syndrome: Systematic Review of Treatment Success.

Authors:  Candace L Brown; Magda Rizer; Ryan Alexander; Emerson E Sharpe; Paul J Rochon
Journal:  Semin Intervent Radiol       Date:  2018-04-05       Impact factor: 1.513

Review 2.  Interventional therapies for controlling pelvic pain: what is the evidence?

Authors:  Isabel C Green; Sarah L Cohen; Dayna Finkenzeller; Paul J Christo
Journal:  Curr Pain Headache Rep       Date:  2010-02

Review 3.  Management of Patients when Superficial Venous Disease Arises from Pelvic Escape Points.

Authors:  Rakesh S Ahuja; Tushar Garg; Deepak Sudheendra
Journal:  Semin Intervent Radiol       Date:  2021-06-03       Impact factor: 1.780

Review 4.  Female Pelvic Vein Embolization: Indications, Techniques, and Outcomes.

Authors:  Anthony James Lopez
Journal:  Cardiovasc Intervent Radiol       Date:  2015-03-25       Impact factor: 2.740

5.  Evaluation of embolization for periuterine varices involving chronic pelvic pain secondary to pelvic congestion syndrome.

Authors:  Flavio Meirelles Siqueira; Lucas Moretti Monsignore; Julio Cesar Rosa-E-Silva; Omero Benedicto Poli-Neto; Luis Henrique de Castro-Afonso; Guilherme Seizem Nakiri; Valdair Francisco Muglia; Daniel Giansante Abud
Journal:  Clinics (Sao Paulo)       Date:  2016-12-01       Impact factor: 2.365

Review 6.  Pelvic vein incompetence: clinical perspectives.

Authors:  David M Riding; Vivak Hansrani; Charles McCollum
Journal:  Vasc Health Risk Manag       Date:  2017-11-27

7.  Hemodynamic and Radiological Classification of Ovarian Veins System Insufficiency.

Authors:  Cezary Szary; Justyna Wilczko; Michal Zawadzki; Tomasz Grzela
Journal:  J Clin Med       Date:  2021-02-08       Impact factor: 4.241

8.  Location and hemodynamic role of perforating veins independent of saphenous veins.

Authors:  Carlos Alberto Engelhorn; Jheneffer Kely Soares Escorsin; Karen Christine Oliveira Costa; Larissa Miyashiro; Melissa de Morais Silvério; Raquel Cristine Gomes da Costa
Journal:  J Vasc Bras       Date:  2018 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.